Literature DB >> 12354504

Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis.

Emilio Pérez-Trallero, Diego Vicente, Mila Montes, Ramón Cisterna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12354504     DOI： 10.1016/S0140-6736(02)11061-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  16 in total

1.  First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy.

Authors:  Paola Stefanelli; Cecilia Fazio; Arianna Neri; Tonino Sofia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 2.  The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine.

Authors:  Robert Welte; Caroline L Trotter; W John Edmunds; Maarten J Postma; Philippe Beutels
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

4.  Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.

Authors:  Martin C J Maiden; Ana Belén Ibarz-Pavón; Rachel Urwin; Stephen J Gray; Nicholas J Andrews; Stuart C Clarke; A Mark Walker; Meirion R Evans; J Simon Kroll; Keith R Neal; Dlawer A A Ala'aldeen; Derrick W Crook; Kathryn Cann; Sarah Harrison; Richard Cunningham; David Baxter; Edward Kaczmarski; Jenny Maclennan; J Claire Cameron; James M Stuart
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

5.  Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains.

Authors:  Amanda J Beddek; Ming-Shi Li; J Simon Kroll; T William Jordan; Diana R Martin
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 6.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Potential capsule switching from serogroup Y to B: The characterization of three such Neisseria meningitidis isolates causing invasive meningococcal disease in Canada.

Authors:  Raymond Sw Tsang; Dennis Ks Law; Shaun D Tyler; Gwen S Stephens; Mark Bigham; Wendell D Zollinger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

8.  Influence of two vaccination campaigns on genetic diversity of invasive Neisseria meningitidis isolates in northern Spain (1997-2008).

Authors:  Diego Vicente; Olatz Esnal; M José López de Goicoechea; Ramón Cisterna; Emilio Pérez-Trallero
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

9.  B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain.

Authors:  Jesús Castilla; Julio A Vázquez; Celia Salcedo; Manuel García Cenoz; José Javier García Irure; Luis Torroba; Xabier Beristain; Raquel Abad; Aurelio Barricarte
Journal:  J Clin Microbiol       Date:  2008-12-17       Impact factor: 5.948

Review 10.  Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

Authors:  Caroline L Trotter; Martin C J Maiden
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.